Literature DB >> 28479360

Impact of Chemical Structure on Conjunctival Drug Permeability: Adopting Porcine Conjunctiva and Cassette Dosing for Construction of In Silico Model.

Eva Ramsay1, Marika Ruponen2, Théo Picardat2, Unni Tengvall2, Marjo Tuomainen2, Seppo Auriola2, Elisa Toropainen2, Arto Urtti3, Eva M Del Amo2.   

Abstract

Conjunctiva occupies most of the ocular surface area, and conjunctival permeability affects ocular and systemic drug absorption of topical ocular medications. Therefore, the aim of this study was to obtain a computational in silico model for structure-based prediction of conjunctival drug permeability. This was done by employing cassette dosing and quantitative structure-property relationship (QSPR) approach. Permeability studies were performed ex vivo across fresh porcine conjunctiva and simultaneous dosing of a cassette mixture composed of 32 clinically relevant drug molecules with wide chemical space. The apparent permeability values were obtained using drug concentrations that were quantified with liquid chromatography tandem-mass spectrometry. The experimental data were utilized for building a QSPR model for conjunctival permeability predictions. The conjunctival permeability values presented a 17-fold range (0.63-10.74 × 10-6 cm/s). The final QSPR had a Q2 value of 0.62 and predicted the external test set with a mean fold error of 1.34. The polar surface area, hydrogen bond donor, and halogen ratio were the most relevant descriptors for defining conjunctival permeability. This work presents for the first time a predictive QSPR model of conjunctival drug permeability and a comprehensive description on conjunctival isolation from the porcine eye. The model can be used for developing new ocular drugs.
Copyright © 2017 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  QSPR; absorption; ophthalmic drug delivery; partial least square; permeability; principal component analysis

Mesh:

Year:  2017        PMID: 28479360     DOI: 10.1016/j.xphs.2017.04.061

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  10 in total

1.  Characterization of artificially re-pigmented ARPE-19 retinal pigment epithelial cell model.

Authors:  Laura Hellinen; Marja Hagström; Heidi Knuutila; Marika Ruponen; Arto Urtti; Mika Reinisalo
Journal:  Sci Rep       Date:  2019-09-24       Impact factor: 4.379

2.  Retinal Pigment Epithelial Cell Line with Fast Differentiation and Improved Barrier Properties.

Authors:  Laura Hellinen; Lea Pirskanen; Unni Tengvall-Unadike; Arto Urtti; Mika Reinisalo
Journal:  Pharmaceutics       Date:  2019-08-13       Impact factor: 6.321

3.  Distribution of Small Molecular Weight Drugs into the Porcine Lens: Studies on Imaging Mass Spectrometry, Partition Coefficients, and Implications in Ocular Pharmacokinetics.

Authors:  Emma M Heikkinen; Seppo Auriola; Veli-Pekka Ranta; Nicholas J Demarais; Angus C Grey; Eva M Del Amo; Elisa Toropainen; Kati-Sisko Vellonen; Arto Urtti; Marika Ruponen
Journal:  Mol Pharm       Date:  2019-08-08       Impact factor: 4.939

4.  Comparative Assessment of Distribution Characteristics and Ocular Pharmacokinetics of Norvancomycin Between Continuous Topical Ocular Instillation and Hourly Administration of Eye Drop.

Authors:  Wenxiang Lin; Libei Zhao; Xuetao Huang; Qian Tan; Manqiang Peng; Muhammad Ahmad Khan; Ding Lin
Journal:  Drug Des Devel Ther       Date:  2020-02-26       Impact factor: 4.162

5.  Microflow-Based Device for In Vitro and Ex Vivo Drug Permeability Studies.

Authors:  Samu Hemmilä; Marika Ruponen; Elisa Toropainen; Unni Tengvall-Unadike; Arto Urtti; Pasi Kallio
Journal:  SLAS Technol       Date:  2020-04-30       Impact factor: 3.047

Review 6.  Nanotechnology for Topical Drug Delivery to the Anterior Segment of the Eye.

Authors:  Alexander Vaneev; Victoria Tikhomirova; Natalia Chesnokova; Ekaterina Popova; Olga Beznos; Olga Kost; Natalia Klyachko
Journal:  Int J Mol Sci       Date:  2021-11-16       Impact factor: 5.923

7.  5-(Sulfamoyl)thien-2-yl 1,3-oxazole inhibitors of carbonic anhydrase II with hydrophilic periphery.

Authors:  Stanislav Kalinin; Alexander Kovalenko; Annika Valtari; Alessio Nocentini; Maxim Gureev; Arto Urtti; Mikhail Korsakov; Claudiu T Supuran; Mikhail Krasavin
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.051

8.  Partitioning and Spatial Distribution of Drugs in Ocular Surface Tissues.

Authors:  Anusha Balla; Seppo Auriola; Angus C Grey; Nicholas J Demarais; Annika Valtari; Emma M Heikkinen; Elisa Toropainen; Arto Urtti; Kati-Sisko Vellonen; Marika Ruponen
Journal:  Pharmaceutics       Date:  2021-05-04       Impact factor: 6.321

9.  Ex Vivo Conjunctival Retention and Transconjunctival Transport of Poorly Soluble Drugs Using Polymeric Micelles.

Authors:  Silvia Pescina; Leticia Grolli Lucca; Paolo Govoni; Cristina Padula; Elena Del Favero; Laura Cantù; Patrizia Santi; Sara Nicoli
Journal:  Pharmaceutics       Date:  2019-09-14       Impact factor: 6.321

10.  Drug Flux Across RPE Cell Models: The Hunt for An Appropriate Outer Blood-Retinal Barrier Model for Use in Early Drug Discovery.

Authors:  Laura Hellinen; Heidi Hongisto; Eva Ramsay; Kai Kaarniranta; Kati-Sisko Vellonen; Heli Skottman; Marika Ruponen
Journal:  Pharmaceutics       Date:  2020-02-19       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.